UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | E | G | H | L | M | N | P | R | S | W
Number of items: 39.

A

Ahmed, SM; Al, H; Reid, WM; Johnson, MA; Poulter, LW; (2002) The cellular response associated with cervical intraepithelial neoplasia in HIV+ and HIV- subjects. Scandinavian Journal of Immunology , 56 (2) 204 - 211.

B

Barry, SM; Condez, A; Johnson, MA; Janossy, G; (2002) Determination of bronchoalveolar lavage leukocyte populations by flow cytometry in patients investigated for respiratory disease-. CYTOMETRY , 50 (6) 291 - 297.

Barry, SM; Lipman, MC; Deery, A; Johnson, MA; Janossy, G; (2002) Immune reconstruction pneumonitis following Pneumocystis carinii pneumonia in HIV-infected subjects. HIV Medicine , 3 (3) 207 - 211.

Besnier, C.; Takeuchi, Y.; Towers, G.; (2002) Restriction of lentivirus in monkeys. Proceedings of the National Academy of Sciences , 99 (18) pp. 11920-11925. 10.1073/pnas.172384599.

Brett, PJ; Tiwana, H; Feavers, IM; Charalambous, BM; (2002) Characterization of oligopeptides that cross-react with carbohydrate-specific antibodies by real time kinetics, in-solution competition enzyme-linked immunosorbent assay, and immunological analyses. J BIOL CHEM , 277 (23) 20468 - 20476. 10.1074/jbc.M200387200. Gold open access

C

Charalambous, BM; (2002) Meningitis B vaccine. PCT/GB.

D

Deayton, JR; Sabin, CA; Britt, WB; Jones, IM; Wilson, P; Johnson, MA; ... Emery, VC; + view all (2002) Rapid reconstitution of humoral immunity against cytomegalovirus but not HIV following highly active antiretroviral therapy. AIDS , 16 (16) 2129 - 2135.

E

Emery, VC; Hassan-Walker, AF; (2002) Focus on new drugs in development against human cytomegalovirus. DRUGS , 62 (13) 1853 - 1858.

Emery, VC; Hassan-Walker, AF; Burroughs, AK; Griffiths, PD; (2002) Human cytomegalovirus (HCMV) replication dynamics in HCMV-naive and -experienced immunocompromised hosts. J INFECT DIS , 185 (12) 1723 - 1728. Green open access
file

G

Gillespie, SH; (2002) Evolution of drug resistance in Mycobacterium tuberculosis: Clinical and molecular perspective. ANTIMICROB AGENTS CH , 46 (2) 267 - 274.

Gillespie, SH; (2002) Microbes sans frontieres. LANCET , 359 (9301) 93 - 95.

Gillespie, SH; (2002) Organisms of surgical importance. Surgery , 20 186 - 189.

Gillespie, SH; (2002) Treatment of skin infections. PRESCRIBER

Gillespie, SH; (2002) Migrating worms. In: Armstrong Cohen, J, (ed.) Infectious Diseases. Elsevier Science Press

Gillespie, SH; (2002) New quinolones for respiratory infections: mechanisms of action and resistance. (Royal Society of Medicine, Round Table Series 76 ). Royal Society of Medicine: London.

Gillespie, SH; Billington, OJ; Breathnach, A; McHugh, TD; (2002) Multiple drug resistant tuberculosis: evidence for changing fitness on passage through human hosts. Microbial Drug Resistance , 8 1 - 7.

Gillespie, SH; Gosling, R; Charalambous, BM; (2002) A re-iterative method for calculating the early bactericidan activity of anti-tuberculosis drugs. American Journal of Respiratory and Critical Care Medicine , 166 (1) 31 - 35.

Gillespie, SH; Gosling, RD; Charalambous, BM; (2002) A reiterative method for calculating bactericidal activity of antituberculosis drugs. American Journal of Respiratory and Critical Care Medicine , 166 (1) 31 - 35.

Gillespie, SH; Gosling, RD; Charalambous, BM; (2002) A reiterative method for calculating the early bactericidal activity of antituberculosis drugs. AM J RESP CRIT CARE , 166 (1) 31 - 35. 10.1164/rccm.2112077.

Gillespie, SH; Tillotson, GS; (2002) Novel perspectives in antibacterial action. (Royal Society of Medicine, Round Table Series 76 ). Royal Society of Medicine

Gillespie, SH; Voelker, LL; Dickens, A; (2002) Evolutionary barriers to quinolone resistance in Streptococcus pneumoniae. MICROB DRUG RESIST , 8 (2) 79 - 84.

H

Hassan-Walker, AF; Emery, VC; Griffiths, PD; (2002) Molecular diagnosis of cytomegalovirus disease. In: Trull, A and Demers, LM and Holt, DW and Johnston, A and Tredger, JM and Price, CP, (eds.) BIOMARKERS OF DISEASE: AN EVIDENCE-BASED APPROACH. (pp. 467 - 473). CAMBRIDGE UNIV PRESS

Herrero-Martinez, E; Sabin, CA; Evans, JG; Griffioen, A; Lee, CA; Emery, VC; (2002) The prognostic value of a single hepatitis C virus RNA load measurement taken early after human immunodeficiency virus seroconversion. J INFECT DIS , 186 (4) 470 - 476.

L

Leśnikowski, ZJ; Paradowska, E; Przepiórkiewicz, M; Olejniczak, A; Emery, VC; (2002) [Drugs against human cytomegalovirus]. Pol Merkur Lekarski , 13 (75) 242 - 249.

Lock, MJ; Thorley, N; Teo, J; Emery, VC; (2002) Azidodeoxythymidine and didehydrodeoxythymidine as inhibitors and substrates of the human herpesvirus 8 thymidine kinase. J ANTIMICROB CHEMOTH , 49 (2) 359 - 366.

M

Maguire, H; Dale, JW; McHugh, TD; Butcher, PD; Gillespie, SH; Costetsos, A; ... Banerjee, DK; + view all (2002) Molecular epidemiology of tuberculosis in London 1995-7 showing low rate of active transmission. THORAX , 57 (7) 617 - 622.

Mays, S; Fysh, E; Taylor, GM; (2002) Periostitic rib lesions – a sign of pulmonary tuberculosis? American Journal of Physical Anthropology , 119 (1) 27 - 36.

Mays, S; Taylor, GM; (2002) Osteological and biomolecular study of two possible cases of hypertrophic osteoarthropathy from Mediaeval England. Journal of Archaeological Science , 29 1267 - 1276.

Mistry, NF; Iyer, AM; D souza, DTB; Taylor, GM; Young, DB; Antia, NH; (2002) Mycobacterium tuberculosis Isolates from Multiple-Drug-Resistant Tuberculosis Patients from Bombay, India. Journal of Clinical Microbiology , 40 2677 - 2680.

N

Nokta, MA; Holland, F; De Gruttola, V; Emery, VC; Jacobson, MA; Griffiths, P; ... Int CMV Prophylaxis Study Grp,; + view all (2002) Cytomegalovirus (CMV) polymerase chain reaction profiles in individuals with advanced human immunodeficiency virus infection: Relationship to CMV disease. J INFECT DIS , 185 (12) 1717 - 1722.

P

Phillips, AN; Staszewski, S; Lampe, F; Youle, MS; Klauke, S; Bickel, M; ... Royal Free Ctr HIV Med Goethe Univ,; + view all (2002) Human immunodeficiency virus rebound after suppression to < 400 copies/mL during initial highly active antiretroviral therapy regimens, according to prior nucleoside experience and duration of suppression. JOURNAL OF INFECTIOUS DISEASES , 186 (8) 1086 - 1091. Green open access
file

Pillay, D; Emery, VC; Mutimer, D; Ogilvie, MM; Carman, W; Mutton, K; ... Public Hlth Laboratory Service Adv,; + view all (2002) Guidelines for laboratory monitoring of treatment of persistent virus infections. J CLIN VIROL , 25 (1) 73 - 92.

R

Ruddy, M; McHugh, TD; Dale, JW; Banerjee, D; Maguire, H; Wilson, P; ... Gillespie, SH; + view all (2002) Estimation of the rate of unrecognized cross-contamination with Mycobacterium tuberculosis in London microbiology laboratories. J CLIN MICROBIOL , 40 (11) 4100 - 4104. 10.1128/JCM.40.11.4100-4104.2002.

S

Sabin, CA; Emery, V; Devereux, HL; Griffioen, AA; Bishop, J; Dusheiko, G; ... Lee, CA; + view all (2002) Long-term patterns of hepatitis C virus RNA concentrations in a cohort of HIV seronegative men with bleeding disorders. J MED VIROL , 68 (1) 68 - 75. 10.1002/jmv.10171.

Sabin, CA; Griffioen, A; Yee, TT; Emery, VC; Herrero-Martinez, E; Phillips, AN; Lee, CA; (2002) Markers of HIV-1 disease progression in individuals with haemophilia coinfected with hepatitis C virus: a longitudinal study. LANCET , 360 (9345) 1546 - 1551.

W

Whalley, S; Brown, D; Webster, G; Jacobs, R; Teo, CG; Emery, V; Dusheiko, G; (2002) Evolution of hepatitis B virus during primary infection: Relevance to virulence and outcome. J HEPATOL , 36 95 - 95.

Whalley, SA; Brown, D; Webster, GJM; Jacobs, R; Teo, CG; Emery, VC; Dusheiko, GM; (2002) Evolution of hepatitis B virus during primary infection. GUT , 50 A118 - A118.

Whalley, SA; Webster, GJM; Brown, D; Teo, CG; Bertoletti, A; Emery, VC; Dusheiko, GM; (2002) Transient generation of core CD8+ cytotoxic T-cell escape mutants during primary HBV infection. GUT , 50 A112 - A112.

Whiting, GC; Evans, JT; Patel, S; Gillespie, SH; (2002) Purification of native alpha-enolase from Streptococcus pneumoniae that binds plasminogen and is immunogenic. J MED MICROBIOL , 51 (10) 837 - 843.

This list was generated on Tue Feb 24 14:34:53 2015 GMT.